학술논문

SIRPa1 macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab
Document Type
Article
Source
In: Blood Advances. (Blood Advances, 14 June 2022, 6(11):3286-3293)
Subject
Language
English
ISSN
24739537
24739529